Espace Jeunes FCOMTE

Main Menu

  • Home
  • French banks
  • French Economy
  • Young People Space
  • French University
  • University Fund

Espace Jeunes FCOMTE

Header Banner

Espace Jeunes FCOMTE

  • Home
  • French banks
  • French Economy
  • Young People Space
  • French University
  • University Fund
French University
Home›French University›French company makes first sale of “artificial” heart, World News

French company makes first sale of “artificial” heart, World News

By Lisa Perez
July 20, 2021
0
0



The French manufacturer of prostheses Carmat announced Monday that it had sold one of its artificial hearts for the first time since its creation in 2008, to implant it in an Italian patient awaiting a transplant.

The operation “was carried out by the team led by cardiac surgeon Dr Ciro Maiello at the Azienda Ospedaliera dei Colli Hospital in Naples, one of the centers with the greatest experience in the field of artificial hearts in Italy”, Carmat said in a statement.

The company obtained a European CE mark in December 2020 for the sale of the Aeson prosthetic heart as a ‘bridge to transplantation’.

This certification was based on the results of a study known as PIVOTAL, launched in 2016 and still ongoing.

In November 2019, the results of the first 11 patients in the study showed that 73% survived for six months with the prosthesis or were successful in a transplant during the same period.

Carmat said the first commercial sale of her artificial heart marks “a major milestone that opens a new chapter in the company’s development”, adding that she hopes to find more customers in France and Germany by the end. of the year.

A spokesperson told AFP it was the first time that one of the hearts has been used outside of a clinical trial.

The costs of the operation – more than 150,000 euros ($ 177,000) – were paid by the regional health system, as Italy’s national system will only cover the treatment when it has been in use for several years.

On July 15, Carmat announced the first implantation of an Aeson heart in a patient in the United States, as part of a clinical study at Duke University Hospital in Durham, North Carolina.

She is looking for 10 suitable patients to participate in a study approved by the United States Food and Drug Administration.



Related posts:

  1. Billionaire Covid who needs to put undocumented immigrants in America’s finest faculties
  2. My later rediscovery of Jane Austen
  3. 5 Indo-American researchers awarded prestigious Guggenheim scholarships for 2021 | Indian of the world
  4. Joan Mitchell, extra like a poet
Tagsunited states

Recent Posts

  • Are the students really too fragile for Shakespeare?
  • From Europe’s powerhouse to its weakest link: Germany’s economy falters
  • Javan Davis Eaton – OBX today
  • Amazon Layaway: a new advantage of Amazon Prime
  • Jeney McCoy – The Santa Barbara Independent

Archives

  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • September 2020
  • August 2020
  • April 2020
  • March 2020
  • February 2020

Categories

  • French banks
  • French Economy
  • French University
  • University Fund
  • Young People Space
  • Terms and Conditions
  • Privacy Policy